Literature DB >> 1301118

A short multilingual quality of life questionnaire--practicability, reliability and interlingual homogeneity.

H Tüchler1, S Hofmann, M Bernhart, M Brugiatelli, L Chrobak, A Franke, M Herold, J Holowiecki, R Ihle, B Jaksic.   

Abstract

International cooperative clinical trials require a multilingual quality of life questionnaire. The 'International Society for Chemo- and Immunotherapy' therefore designed a study to develop and test a 'health accentuated' quality of life questionnaire in the eight languages spoken in this society. The objective was to examine practicability, reliability and interlingual homogeneity. Versions of the questionnaire in Czech, German, Hungarian, Italian, Kroatian, Polish, Romanian and Slovakian have been prepared. The results are based on data of 1,104 adult patients. They demonstrate that the developed questionnaire is practicable. Patients need 10-15 min to answer it, usually without assistance. The proportion of missing values is for all but two questions less than 3%. The questionnaire also found high acceptance reflected by only 2.7% refusals. It is reasonably reliable in each language. Interlingual homogeneity could be shown by demonstration of strong structural similarities between the different versions using multidimensional scaling, factor analysis and comparison of mean profiles.

Entities:  

Mesh:

Year:  1992        PMID: 1301118     DOI: 10.1007/bf00439718

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  7 in total

1.  Maximum validity of a test with equivalent items.

Authors:  L R TUCKER
Journal:  Psychometrika       Date:  1946-03       Impact factor: 2.500

Review 2.  Quality of life end points in cancer clinical trials: review and recommendations.

Authors:  C M Moinpour; P Feigl; B Metch; K A Hayden; F L Meyskens; J Crowley
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

Review 3.  Quality of life research in oncology. Past achievements and future priorities.

Authors:  N K Aaronson; B E Meyerowitz; M Bard; J R Bloom; F I Fawzy; M Feldstein; D Fink; J C Holland; J E Johnson; J T Lowman
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

Review 4.  Measuring quality of life today: methodological aspects.

Authors:  D F Cella; D S Tulsky
Journal:  Oncology (Williston Park)       Date:  1990-05       Impact factor: 2.990

5.  A modular approach to quality-of-life assessment in cancer clinical trials.

Authors:  N K Aaronson; M Bullinger; S Ahmedzai
Journal:  Recent Results Cancer Res       Date:  1988

Review 6.  Measuring quality of life in cancer patients.

Authors:  K Donovan; R W Sanson-Fisher; S Redman
Journal:  J Clin Oncol       Date:  1989-07       Impact factor: 44.544

Review 7.  Methodologic issues in assessing the quality of life of cancer patients.

Authors:  N K Aaronson
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

  7 in total
  3 in total

Review 1.  Multidimensional scaling as a tool for analysing quality of life data.

Authors:  G Kemmler; B Holzner; M Kopp; M Dünser; R Greil; E Hahn; B Sperner-Unterweger
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

2.  Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma.

Authors:  Raimund Waldner; Claudia Laschan; Alfred Lohninger; Martin Gessner; Heinz Tüchler; Marlies Huemer; Wolfgang Spiegel; Heidrun Karlic
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-08       Impact factor: 4.553

Review 3.  Cardioprotective interventions for cancer patients receiving anthracyclines.

Authors:  Elvira C van Dalen; Huib N Caron; Heather O Dickinson; Leontien Cm Kremer
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.